Product Reimbursement Assistance
Jazz Pharmaceuticals offers support and guidance on reimbursement through our Patient Affairs area to patients and providers for our chronic, patient-administered products, as we understand the challenges you may be facing in obtaining your product and/or insurance coverage. Patient Assistance Programs Jazz Pharmaceuticals currently provides Patient Assistance Programs on Xyrem for U.S. patients who are uninsured and/or underinsured, through the National Organization of Rare Disorders, Inc. (NORD), a non-profit organization dedicated to the identification, treatment and cure of rare ?orphan diseases." Please contact the XYREM success program for more information (1-866-XYREM88). Xyrem? (sodium oxybate) oral solution: Reimbursement assistance is available through the Xyrem Success Program? for registered patients. Please call 1-866-XYREM88 (1-866-997-3688) or visit the www.xyrem.com website for more information.

Our Mission
- Improve patients' lives
- Develop valuable products in psychiatry and neurology
- Always keep patients firmly in mind
Our Inspiration
- Addressing poorly understood conditions and underserved patients
- Improving patient care and developing valuable programs for physicians and patients
News
01/07/2010 | Press ReleaseJazz Pharmaceuticals to Present at 2010 J.P. Morgan Healthcare Conference
12/15/2009 | Press Release
Jazz Pharmaceuticals Submits New Drug Application for JZP-6 (sodium oxybate) for the Treatment of Fibromyalgia
12/03/2009 | Press Release
Jazz Pharmaceuticals Appoints Kathryn Falberg as Chief Financial Officer